Mark Taylor is a veteran healthcare journalist who writes for newspapers, online news organizations and healthcare industry business publications. He was a staff reporter for the Gary (Indiana) Post-Tribune and legal affairs reporter for Crain’s Modern Healthcare Magazine. He writes about the business, financing, policy and delivery of healthcare. Taylor is a co-founder of the Association of Health Care Journalists. Taylor lives in Munster, Indiana.
In a study published Tuesday in JAMA, Anthem subsidiary CareMore Health Plan demonstrated how it collaborated with the ride service Lyft to reduce patient waiting times by 30 percent and cut per-ride costs by 32.4 percent.
The consortium will use induced pluripotent stem cell (iPSC) technology — a type of stem cell that can be generated from adult stem cells — to find better treatments for the two psychiatric conditions.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
ClearCare has raised $76 million to date from Battery Ventures, McKesson, Bessemer Venture Partners, Voyager Capital, Cambia Health Solutions and Qualcomm Ventures.
Thar produces an oral version of an existing intravenous drug used to treat the estimated 80,000 Americans diagnosed annually with complex regional pain syndrome.
"This brings us much closer to a ‘lingua franca’ for health information, so clinicians finally have complete information available about their patients.”
Aspect Imaging and design firm frog are working together to develop a new MRI technology that's cheaper and can be placed outside shielded areas in a hospital.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
CVRx, which has struggled to get the FDA nod for an earlier generation device, will use the money to progress its pivotal clinical trial in the U.S. to treat patients with congestive heart failure using neuromodulation.
The collaborative brings together more acronyms than an army battle map, international drug research expertise and as much as $350 million in funding to tackle this looming crisis.
Bruin Biometrics is connecting its wireless pressure ulcer detector, the SEM Scanner, to a digital registry for pressure ulcers known as PUNT (Pressure Ulcer Notification Tool).
Sanford Health, a 43-hospital health system based in Sioux Falls, South Dakota, has contracted with Bellevue, Washington-based Translational Software to provide pharmacogenomics services to its hospitals and nearly 250 clinics in nine states.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
The Fisher Center for Alzheimer's Research Foundation is funding a new technology that allows greater visualization of amyloid plaques as well as other Alzheimer’s markers, such as tau proteins and vasculature and microglia activation.
In another recent member poll, physicians found problems in patient diagnoses gleaned from the Internet.
The bill, known as the ESRD Choice Act (H.R. 5?659), would allow enrollment in the Medicare managed care plans to ESRD patients undergoing dialysis treatment.
“It was driven by the recognition that fundamentally the biological platform for both companies was a mirror image. We both independently uncovered the biology of the immune-microbiome.”
In the revaluation, the onetime Silicon Valley darling allowed large investors to increase their ownership stake in the company in the wake of a scandal.